Breathing. That critical inhale/exhale operation of the lungs is something we often take for granted — until something goes wrong and respiratory problems result. The Center for Acute Respiratory ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Please provide your email address to receive an email when new articles are posted on . Among patients receiving extracorporeal membrane oxygenation, the presence of obesity did not impact mortality ...
San Antonio, Texas – June 3, 2024 – Recognizing an unusual prevalence of bloodstream infections (BSI) that threatened extremely ill patients receiving Extracorporeal Membrane Oxygenation, or ECMO, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HONOLULU -- In ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A higher likely risk for mortality in ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback